Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$116.10Cboe Real-Time Last Sale as of 1:25PM ET 8/23/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-7.39(5.98%)
Bid (Size)$116.14 (200)
Ask (Size)$116.22 (121)
Day Low / High$115.84 - 124.02
Volume3.1 M

Alexion Pharmaceuticals Gets FDA Nod for Soliris for Autoimmune Disease, Stock Rises

2:54PM ET 6/27/2019 MT Newswires
Alexion Pharmaceuticals (ALXN) said on Thursday the US Food and Drug Administration has approved Soliris for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare but severe autoimmune disease that attacks the central nervous system in adult patients.

"Each attack can result in potentially irreversible consequences -- causing blindness or losing the ability to walk -- so preventing relapse is the primary goal," said Michael Levy at Massachusetts General Hospital. "There is now for the first time an FDA-approved treatment available to NMOSD patients to help reduce the risk of relapse."

Price: 126.06, Change: +0.72, Percent Change: +0.57